Turkey · Delayed Price · Currency is TRY CTI BioPharma Statistics
Total Valuation
IST:SONME has a market cap or net worth of TRY 9.47 billion. The enterprise value is 9.40 billion.
| Market Cap | 9.47B |
| Enterprise Value | 9.40B |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IST:SONME has 74.00 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 74.00M |
| Shares Outstanding | 74.00M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 51.13% |
| Owned by Institutions (%) | n/a |
| Float | 4.25M |
Valuation Ratios
The trailing PE ratio is 57.29.
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | 57.29 |
| Forward PE | n/a |
| PS Ratio | 56.72 |
| PB Ratio | 2.40 |
| P/TBV Ratio | 2.40 |
| P/FCF Ratio | 30.42 |
| P/OCF Ratio | 30.46 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 59.19, with an EV/FCF ratio of 30.20.
| EV / Earnings | 56.87 |
| EV / Sales | 56.30 |
| EV / EBITDA | 59.19 |
| EV / EBIT | 59.76 |
| EV / FCF | 30.20 |
Financial Position
The company has a current ratio of 2.78
| Current Ratio | 2.78 |
| Quick Ratio | 2.78 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 15,856.91 |
Financial Efficiency
Return on equity (ROE) is 6.71% and return on invested capital (ROIC) is 3.99%.
| Return on Equity (ROE) | 6.71% |
| Return on Assets (ROA) | 3.59% |
| Return on Invested Capital (ROIC) | 3.99% |
| Return on Capital Employed (ROCE) | 3.54% |
| Revenue Per Employee | 41.75M |
| Profits Per Employee | 41.33M |
| Employee Count | 4 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IST:SONME has paid 219.26 million in taxes.
| Income Tax | 219.26M |
| Effective Tax Rate | 57.01% |
Stock Price Statistics
The stock price has increased by +64.91% in the last 52 weeks. The beta is 1.47, so IST:SONME's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | +64.91% |
| 50-Day Moving Average | 120.47 |
| 200-Day Moving Average | 100.18 |
| Relative Strength Index (RSI) | 49.48 |
| Average Volume (20 Days) | 76,667 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IST:SONME had revenue of TRY 167.01 million and earned 165.32 million in profits. Earnings per share was 2.23.
| Revenue | 167.01M |
| Gross Profit | 165.69M |
| Operating Income | 157.33M |
| Pretax Income | 384.59M |
| Net Income | 165.32M |
| EBITDA | 158.87M |
| EBIT | 157.33M |
| Earnings Per Share (EPS) | 2.23 |
Balance Sheet
The company has 69.41 million in cash and n/a in debt, giving a net cash position of 69.41 million or 0.94 per share.
| Cash & Cash Equivalents | 69.41M |
| Total Debt | n/a |
| Net Cash | 69.41M |
| Net Cash Per Share | 0.94 |
| Equity (Book Value) | 3.94B |
| Book Value Per Share | 53.24 |
| Working Capital | 48.22M |
Cash Flow
In the last 12 months, operating cash flow was 310.95 million and capital expenditures 443,441, giving a free cash flow of 311.40 million.
| Operating Cash Flow | 310.95M |
| Capital Expenditures | 443,441 |
| Free Cash Flow | 311.40M |
| FCF Per Share | 4.21 |
Margins
Gross margin is 99.21%, with operating and profit margins of 94.21% and 98.99%.
| Gross Margin | 99.21% |
| Operating Margin | 94.21% |
| Pretax Margin | 230.28% |
| Profit Margin | 98.99% |
| EBITDA Margin | 95.13% |
| EBIT Margin | 94.21% |
| FCF Margin | 186.46% |
Dividends & Yields
IST:SONME does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | n/a |
| Earnings Yield | 1.75% |
| FCF Yield | 3.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 19, 2021. It was a forward split with a ratio of 1.3198965.
| Last Split Date | Oct 19, 2021 |
| Split Type | Forward |
| Split Ratio | 1.3198965 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |